National News

Action required: Fax messages received by incorrect recipient

PSNC News - 4 February 2019 - 4:29pm

NHS England’s Corporate Information Governance team has been notified by a hotel group that a number of faxes appear to have been inadvertently sent to them over the past weeks by GP practices and community pharmacies. The items faxed through have been sent from providers across the country and contain dispensing tokens, certificates and requests for medication. It is therefore likely that the fax numbers in question are very similar to a fax number being used within the healthcare system.

In this specific case the fax numbers that were receiving details inappropriately are: 08444119 012 and 01564 793 558. Pharmacy teams should check that they are not using these numbers as they are not part of the healthcare system. Any breaches of information governance security should be reported so that the incident can be investigated and learning shared where necessary.

NHS England has advised that community pharmacy teams:

  • only use fax where no other communication method is available;
  • before sending a fax, confirm with the recipient that the number is correct; and
  • after sending a fax, confirm with the recipient that they have correctly received your transmission.

It is also important that any changes in a pharmacy’s contact details are shared with relevant healthcare contacts to ensure that information is not sent to out-of-date or out-of-service numbers.

PSNC has published Briefing 053/17: Ten steps to help improve data and cyber security within your pharmacy which contains best practice guidance on processing or communicating sensitive information.

Categories: National News

Shortage of Carbagen (carbamazepine) tablets

PSNC News - 4 February 2019 - 2:48pm

Specialist Pharmacy Service (SPS) advises that there is currently a shortage of Carbagen 200mg and 400mg immediate release (IR) tablets and 200mg and 400mg prolonged release (PR) tablets.

The PR 200mg and 400mg tablets are expected back in stock in late 2019, while the 200mg IR are expected at the end of Q2 2019 and the 400mg IR in late 2019.

Further advice can be found here on the SPS website.

 

Categories: National News

Class 4 MHRA Drug Alert – Amoxicillin 500mg capsules BP (Accord)

PSNC News - 4 February 2019 - 2:14pm

Drug Alert No: EL (19) A/03
Date Issued: 4th February 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for certain batches of Amoxicillin 500mg capsules (Accord).

Amoxicillin 500mg capsules BP (Accord)

PL 200175/0264

Batch Number Expiry Date Pack Size First Distributed  MP 18062  01/2021  1 x 21 04 Oct 2018  MP 18063  01/2021  1 x 21 26 Oct 2018  MP 18064  01/2021  1 x 21 16 Oct 2018

Accord Healthcare Limited has informed MHRA that a change to the Patient Information Leaflet (PIL) for this product has not been implemented by the required timeline. The change concerns the addition of the symptoms of a potential side effect, ‘Drug Reaction with Eosinophilia and Systemic Symptoms’ (DRESS) which is a potentially life-threatening condition. For this reason, it is important that any patients who notice the symptoms seek immediate medical advice.

Advice for community pharmacy teams:

When dispensing this product, please check the Marketing Authorisation Holder and the batch number. If any of the above batch numbers are being dispensed, please remove the PIL in the pack and provide a copy of the correct version, which can be downloaded here.

For medical information enquiries, please contact Accord Medical Information, Tel 01271 385257; email medinfo@accord-healthcare.com

Categories: National News

Quality Payments: Deadline for requesting editing rights for your NHS website profile

PSNC News - 4 February 2019 - 12:38pm

Community pharmacy contractors who do not have editing rights for their NHS website profile must request these via their premises-shared NHSmail account by 5pm on 8th February 2019 to ensure that they receive these by the review date (15th February 2019).

Any requests after this deadline, or requests made via non-NHSmail accounts will increase the risk of a contractor not obtaining editing rights by the review date, which could result in non-compliance with the NHS website gateway criterion as contractors will not be able to update or validate the three sections of their NHS website profile by the review date.

Requests for editing rights after 5pm on 8th February 2019 will not be accepted as a valid reason for not being able to meet the NHS website gateway criterion.

Requesting editing rights

Contractors who do not have editing rights for their NHS website profile will need to email the NHS website service desk (nhswebsite.servicedesk@nhs.net) and include ‘QPSAPPLICATION’ as the subject of the email; if this isn’t used for the subject of the email, it may result in a processing delay and increase the risk of not being able to meet the NHS website gateway criterion.

It is preferable for this email request to come from the pharmacy’s premises shared NHSmail account, as use of other email accounts may lead to a delay in editing rights being granted, while the validity of the request for editing rights is confirmed. To apply for editing rights, contractors should supply the below information, ideally by copying and pasting the table below into an email and completing the required information.

Name: Email address (preferably the pharmacy premises shared NHSmail account) – this will be used as your username on the website: Telephone number: Job title: Organisation: ODS code: Lost passwords

If a contractor has lost their password, they can request a new password on the NHS website.

 

Categories: National News

Quality Payments: Declarations can now be submitted

PSNC News - 4 February 2019 - 11:35am

Community pharmacy contractors are now able to make a declaration for a Quality Payment for the 15th February 2019 review point of the Quality Payments Scheme.

As for previous declarations, contractors wishing to claim a Quality Payment will be required to submit their declaration online to the NHS Business Services Authority (NHSBSA); however, for the February 2019 review point, contractors will be able to claim for a quality payment via one of two routes, the Snap Survey tool (as used for previous declarations) or the Manage Your Service (MYS) application.

In addition, there is a new process for validating a contractor’s submission to confirm if they meet the gateway criteria and actions that contractors will need to take if NHSBSA cannot validate that a contractor’s submission meets all five of the gateway criteria.

PSNC Briefing 007/19: Quality Payments – Completing your declaration provides further information on how to make a declaration and the validation process for the gateway criteria; contractors are strongly encouraged to read this.

Contractors are reminded that the deadline for submitting a declaration for the Quality Payments Scheme is Friday 1st March 2019 at 11.59pm.

NHSBSA gateway criteria report

Contractors are encouraged to check the status of their compliance with the gateway criteria before they make their declaration by accessing the weekly gateway criteria report on the NHSBSA website, which details contractors who have been assessed, using national datasets, as meeting four of the five gateway criteria: NHS website; Advanced Services; Community Pharmacy Patient Questionnaire (CPPQ); and NHSmail (due to cyber security reasons, the report does not contain confirmation on compliance with the Warranted Environment Specification gateway criterion, that has been separately confirmed to contractors via an email sent by the NHSBSA).

The report, which was updated on Friday 1st February 2019, shows that only 7,412 (64%) contractors are currently meeting the four gateway criteria (the fifth gateway criterion, WES, is not included in this report).

Gateway criterion Number of contractors currently meeting the gateway criterion % of contractors currently meeting the gateway criterion NHS website 8,217 71% Advanced Services 11,271 97% CPPQ 10,694 92% NHSmail 9,978 86%

Contractors should be aware that the national datasets used for the report are updated weekly therefore any changes made in the week, will not show on the report until it is updated on the following Friday. For example, if a pharmacy’s NHS website profile is updated on Monday 4th February 2019 this will not show on the report on the NHSBSA website until the updated report is published on Friday 8th February 2019.

Categories: National News

Quality Payments – Completing your declaration (February 2019)

PSNC News - 4 February 2019 - 11:29am

Community pharmacy contractors will be able to make a declaration for a Quality Payment for the 15th February 2019 review point between Monday 4th February 2019 at 9am and Friday 1st March 2019 at 11.59pm.

This PSNC Briefing provides further information on how to make a declaration and the validation process for the gateway criteria.

PSNC Briefing 007/19: Quality Payments – Completing your declaration (February 2019)

If you have any queries on this PSNC Briefing or you require more information, please contact the PSNC Services Team.

To browse other PSNC briefings on services and commissioning click here.

View Article…

Categories: National News

Quality Payments: Updated gateway criteria report now available on NHSBSA website

PSNC News - 1 February 2019 - 2:53pm

The NHS Business Services Authority (NHSBSA) has today updated its weekly gateway criteria report, allowing community pharmacy contractors to check whether they have been assessed as meeting four of the five gateway criteria (Advanced Services, NHS website, Community Pharmacy Patient Questionnaire (CPPQ) and NHSmail) of the Quality Payments Scheme.

Contractors are therefore encouraged to check this report to see if the national datasets show they have met the four gateway criteria as detailed above and if not, take corrective action as soon as possible to ensure they meet the criteria by the review point (15th February 2019).

Contractors should also be aware that this report can change on a weekly basis, for example, a contractor could show as meeting the NHSmail gateway criterion if their shared premises NHSmail account has two active linked NHSmail accounts. However, if one of these accounts becomes inactive before the review point, the report could change to show that the contractor no longer meets the NHSmail gateway criterion. Contractors are therefore encouraged to download the report each week from the NHSBSA website to ensure that their pharmacy continues to meet the four gateway criteria.

Any changes made after each Friday will not be shown until the following week’s update. For example, if a pharmacy’s NHS website profile is updated on Monday 4th February 2019, it will not show on the gateway criteria report on the NHSBSA website until the new report is published on Friday 8th February 2019.

Further information on the gateway criteria report and how contractors will be notified if they meet the fifth gateway criterion (Warranted Environment Specification (WES)) can be found in PSNC’s original news story on the gateway criteria report.

Number of contractors currently meeting the gateway critiera (excluding WES) Gateway criterion Number of contractors currently meeting the gateway criterion % of contractors currently meeting the gateway criterion NHS website 8,217 71% Advanced Services 11,271 97% CPPQ 10,694 92% NHSmail 9,978 86%

Contractors should be aware that the national datasets used for the report are updated weekly therefore any changes made in the week, will not show on the report until it is updated on the following Friday. For example, if a pharmacy’s NHS website profile is updated on Monday 4th February 2019 this will not show on the report on the NHSBSA website until the updated report is published on Friday 8th February 2019.

Categories: National News

Reminder: Help Us Help You campaign starts on 4th February

PSNC News - 1 February 2019 - 12:00pm

Community pharmacy teams should have received a resource pack this week for the Help Us Help You campaign, and are reminded that these materials must be displayed in their pharmacy from Monday 4th February 2019.

PSNC and NHS England have agreed that this will count as one of community pharmacy’s six public health campaigns for the year, so participation in the campaign by displaying the materials is mandatory.

All community pharmacies should have received a resources pack which includes a campaign briefing sheet, double-sided window sticker, shelf wobblers, poster, information cards and a leaflet dispenser.

Further resources available from Public Health England’s Campaign Resource Centre.

If you have any queries about the campaign or have not yet received your pack, please contact: partnerships@phe.gov.uk

PSNC support materials

Minor illnesses resource hub
Community pharmacy teams may wish to familiarise themselves with PSNC’s one-stop resources hub, which links to all the most up-to-date clinical resources on managing minor illnesses, and identifying red flag symptoms.

Categories: National News

Pharmacists will be a vital part of Primary Care Networks, say NHS England

PSNC News - 31 January 2019 - 5:17pm

Following this morning’s announcement of a GP funding deal which will transform primary care, NHS England has confirmed the role that pharmacists will play as part of that transformation.

In the latest Pharmacy and Medicines Bulletin, Chief Pharmaceutical Officer, Dr Keith Ridge, recognises the need to utilise the clinical skills of community pharmacy professionals as NHS England works towards making the Long Term Plan a reality.

The plans include pharmacists becoming part of core general practice teams – enabling patients to access expert advice about medicines much more quickly – and the community pharmacy sector will develop strong links with the emerging Primary Care Networks (PCNs). Dr Ridge states that “subject to contract negotiation, the Digital Minor Illness Referral Service may be extended” and pilot referral services from GP practices to community pharmacies will begin in several PCN areas.

Read the bulletin in full

PSNC Director of NHS Services, Alastair Buxton, said:

“We are pleased to hear the Chief Pharmaceutical Officer recognising the clinical skills that community pharmacy teams possess. It is particularly encouraging to hear that NHS England is planning to discuss the national rollout of the Digital Minor Illness Referral Service and we look forward to starting contract negotiations as soon as possible.”

Categories: National News

Data Security and Protection (IG) Toolkit Workshop now on-demand

PSNC News - 31 January 2019 - 4:45pm

Community pharmacy contractors can now access an online recording of PSNC’s recent online workshop about the Data Security and Protection (IG) Toolkit.

Feedback we have received so far:

“Worth every minute.” – Director/Owner

“Thought it would be a daunting task to complete the toolkit but this webinar helped to reassure me.” – Pharmacist

“The information was very clear, reassuring and the speakers have made the toolkit feel less burdensome. I still have a lot to do but it seems more ‘doable’ now.” – Pharmacy Manager

“Really like the pragmatism of NHS Digital and the clear collaboration between PSNC and NHS Digital.” – LPC Member

“Frankly, the most efficiently delivered webinar I’ve attended.” – Director/Owner

Almost 1,000 people registered for yesterday’s workshop which provided contractors with support in completing their 2018/19 Information Governance (IG) return.

During the webinar, representatives from PSNC and NHS Digital discussed the questions in the Toolkit, talked viewers through the guidance materials available and answered questions on how to make the Information Governance declaration. With contractors required to finalise their pharmacy’s Data Security and Protection Toolkit submission by 31st March 2019, this webinar provides the perfect opportunity to make good headway in its completion.

With contractors required to finalise their pharmacy’s Data Security and Protection Toolkit submission by 31st March 2019, this workshop provides the perfect opportunity to make good headway in its completion.

Click here to view an on-demand version of the webinar.*

You can also click here to view the slide pack used in the webinar.

*Please note, to watch the recording, you will need to register (or input the email address you registered with previously).

Categories: National News

January 2019 Price Concessions/NCSO – final update

PSNC News - 31 January 2019 - 4:00pm

Department of Health and Social Care (DHSC) has today (31/01/2019) set the FINAL price concessions for January 2019.

The new additions to the January 2019 price concessions list are below:

Drug Pack size Price Concession Candesartan 8mg tablets 28 £4.57 Candesartan 16mg tablets 28 £4.22 Citalopram 40mg/ml oral drops sugar free 15ml £10.46 Clomipramine 10mg capsules 28 £1.95 Clomipramine 50mg capsules 28 £4.12 Desmopressin 200mcg tablets 30 £9.21 Glimepiride 4mg tablets 30 £3.52 Irbesartan 150mg tablets 28 £3.19 Irbesartan 300mg tablets 28 £3.58 Lercanidipine 20mg tablets 28 £4.98 Mefenamic acid 500mg tablets 28 £30.42 Metronidazole 400mg tablets 21 £9.23 Metoprolol 50mg tablets 28 £2.78 Naproxen 250mg gastro-resistant tablets 56 £9.52 Naproxen 500mg tablets 28 £12.60 Nebivolol 5mg tablets 28 £4.93 Nortriptyline 25mg tablets 100 £10.02 Ondansetron 4mg tablets 10 £8.78 Orlistat 120mg capsules 84 £26.40 Perindopril erbumine 8mg tablets 30 £3.10 Quetiapine 100mg tablets 60 £9.80 Quetiapine 200mg tablets 60 £25.77 Risperidone 1mg tablets 20 £4.69 Sevelamer 800mg tablets 180 £111.01 Telmisartan 80mg tablets 28 £8.30 Topiramate 100mg tablets 60 £20.96 Topiramate 50mg tablets 60 £11.50

DHSC previously (25.01.2019) granted the following price concessions:

Drug Pack size Price Concession Amiloride 5mg tablets 28 £10.20 Brimonidine 0.2% eye drops 5ml £3.03 Bumetanide 1mg tablets 28 £1.95 Carvedilol 25mg tablets 28 £1.38 Carvedilol 3.125mg tablets 28 £0.86 Carvedilol 6.25mg tablets 28 £0.90 Dosulepin 25mg capsules 28 £3.00 Fluoxetine 20mg capsules 30 £1.05 Glyceryl trinitrate 400micrograms/dose pump sublingual spray 200 £2.15 Hydroxocobalamin 1mg/1ml solution for injection ampoules 5 £9.70 Lercanidipine 10mg tablets 28 £2.78 Levetiracetam 100mg/ml Oral Solution sugar free 300ml £17.50 Lofepramine 70mg tablets 56 £17.20 Naproxen 250mg tablets 28 £6.30 Nortriptyline 10mg tablets 100 £8.00 Propranolol 80mg tablets 56 £2.30 Quetiapine 25mg tablets 60 £4.50 Quetiapine 300mg tablets 60 £13.00 Ramipril 10mg tablets 28 £4.49 Temazepam 10mg tablets 28 £1.46 Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets 28 £4.17 Valsartan 160mg capsules 28 £9.53 Valsartan 80mg capsules 28 £7.25

DHSC previously (21.01.2019) granted the following price concessions

Drug Pack size Price Concession Allopurinol 100mg tablets 28 £1.70 Allopurinol 300mg tablets 28 £3.68 Co-careldopa 25mg/100mg tablets 100 £10.69 Diamorphine 10mg powder for solution for injection ampoules 5 £16.56 Diamorphine 30mg powder for solution for injection ampoules 5 £16.52 Dosulepin 75mg tablets 28 £11.00 Furosemide 20mg tablets 28 £1.25 Furosemide 40mg tablets 28 £2.21 Ibandronic acid 50mg tablets 28 £54.22 Latanoprost 50micrograms/ml eye drops 2.5ml £7.95 Losartan 25mg tablets 28 £5.27 Losartan 50mg tablets 28 £4.50 Losartan 100mg tablets 28 £6.95 Metronidazole 200mg tablets 21 £2.70 Naproxen 500mg gastro-resistant tablets 56 £18.01 Nebivolol 2.5mg tablets 28 £15.85 Quetiapine 150mg tablets 60 £6.60 Ramipril 2.5mg tablets 28 £4.15 Ramipril 5mg tablets 28 £4.15 Risperidone 500microgram tablets 20 £2.72 Risperidone 2mg tablets 60 £21.00 Risperidone 3mg tablets 60 £24.95 Risperidone 4mg tablets 60 £31.88 Sodium valproate 200mg/5ml oral solution sugar free 300 £7.00 Sodium valproate 200mg gastro-resistant tablets 100 £6.25 Sodium valproate 500mg gastro-resistant tablets 100 £17.50 Tadalafil 5mg tablets 28 £23.71 Telmisartan 20mg tablets 28 £3.80 Telmisartan 40mg tablets 28 £6.94 Valsartan 40mg capsules 28 £4.49

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.

Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.

Categories: National News

GP funding deal to transform primary care

PSNC News - 31 January 2019 - 8:02am

NHS England has announced a £4.5bn funding package for GPs in a five-year deal that is designed to transform local healthcare systems.

The deal includes funding that will help to fund the widespread development of Primary Care Networks (PCNs), which will be multi-disciplinary teams of healthcare professionals working together at a local level to deliver joined up patient care. Each PCN will cover around 30-50,000 GP registered patients.

General practice will be at the heart of the PCNs, but NHS England has said that it wants an additional 20,000 people to work alongside GPs in the networks.

This will include a considerable number of clinical pharmacists who will deliver services such as structured medication reviews. Each PCN is expected to have a number of these pharmacists delivering care.

NHS England has confirmed that these PCN pharmacists will not necessarily need to be employed by GP practices, but they will need to work as part of the integrated care team that makes up the PCN.

The funding comes into effect from April 2020, and the changes are expected to amount to a transformation in general practice and primary healthcare services.

Simon Dukes, PSNC Chief Executive, said:

“This funding deal gives us a very clear indication of the way in which HM Government and NHS England want primary care services to develop in the foreseeable future. Progress will be made through multi-disciplinary networks which have GPs at their heart and deliver patient-focused care.

The scale of this transformation is unprecedented, and GPs will undoubtedly benefit from being supported to deliver these changes with a five-year funding package – this is exactly the approach that the NHS must now take with community pharmacies so that we too can play our part in improving local healthcare.

For community pharmacy the changes offer a unique opportunity for us to embed ourselves further within primary care. GPs will be bringing together local healthcare providers into the new networks and we must engage proactively with them and find ways to position ourselves within those PCNs. All pharmacies will need to take steps to work as closely with local GPs as they can. Success will also involve transforming the services that we offer, and community pharmacies will need to be ready for radical changes, such as partnering with other contractors to jointly meet the needs of their local PCN.

PSNC will be working with the other national pharmacy organisations to facilitate all of this. Our objective is for community pharmacies to be fully involved in these multi-disciplinary networks. We must find ways for community pharmacists to perform some of the roles of the PCN clinical pharmacists and we want to work with NHS England to facilitate local engagement to ensure that community pharmacy is at the heart of the developing local plans.

The role of local leadership and engagement will also become more critical than ever, and PSNC will be working with the LPCs to help them through this difficult work, ensuring that they have the skills, capacity and support to succeed.”

Categories: National News

Part VIIIB February 2019 Drug Tariff changes

PSNC News - 30 January 2019 - 3:37pm

Effective from 1st February 2019, the following unlicensed (special) products will be deleted from Part VIIIB of the Drug Tariff:

Clobetasone 0.05%/Oxytetracycline 3%/Nystatin 100,000units/g cream
Clonidine 50micrograms/5ml oral solution
Clonidine 50micrograms/5ml oral suspension

Licensed alternatives for these products (listed below) which are now available will be added to Part VIIIA of Drug Tariff in February 2019.

Clobetasone 0.05%/Oxytetracycline 3%/Nystatin 100,000units/g cream (Trimovate Cream)
Clonidine 50micrograms/5ml oral solution sugar free (Thame Laboratories Ltd)

Any changes to Part VIII of the Drug Tariff impacts reimbursement so it is important to take note when amendments are made to product listings.

Pharmacy staff are advised to take care in ensuring that any prescriptions for the unlicensed products dispensed in January are submitted for payment no later than the 5th February 2019 to ensure your prescriptions are processed in the correct month (for EPS prescriptions the dispense notification must be submitted by the 31st January 2019 with the corresponding claim notification sent no later than the 5th of February 2019). Please note that if any prescriptions for unlicensed products listed above are inadvertently submitted with your February bundle, you would be reimbursed as per the February Drug Tariff Part VIIIA rules and would not be able to claim the ‘SP’ fee for supplying the unlicensed product.

Other Part VIIIB additions

Effective from 1st February 2019 Sertraline 25mg/5ml oral suspension (STD, SF) will be added to Part VIIIB of the Drug Tariff.

Pharmacy staff are advised to take care in ensuring that any prescriptions for Sertraline 25mg/5ml oral suspension (sourced under a manufacturer’s specials/importer’s licence issued by the MHRA) which were dispensed in January are endorsed as per the guidance for unlicensed medicines which are not listed in Part VIIIB of the Drug Tariff and submitted for payment no later than the 5th February 2019 to ensure your prescriptions are processed in the correct month (for EPS prescriptions the dispense notification must be submitted by the 31st January 2019 with the corresponding claim notification sent no later than the 5th of February 2019).

Please note that if any prescriptions for Sertraline 25mg/5ml oral suspension are inadvertently submitted with your February bundle, you would be reimbursed as per the Part VIIIB February Drug Tariff list price.

Categories: National News

NHS Prescription Services ‘Hints & Tips’ – Issue 34

PSNC News - 30 January 2019 - 9:21am

NHS Prescription Services produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 34) contains some useful information and advice on:

  • Do you want to save time on your prescription administration?
  • Proof of exemption from NHS charges
  • Customers can check their exemption status
  • Register your pharmacy for online PPC applications

Click here to access this month’s PDF version of Hints & Tips Dispensing Contractors.

To access previous issues of Hints & Tips click here.

Categories: National News

Quality Payments: Have you completed the relevant CPPE learning packages?

PSNC News - 30 January 2019 - 8:30am

Community pharmacy contractors are reminded that certain members of staff are required to complete one or both of the Centre for Pharmacy Postgraduate Education (CPPE) learning packages and e-assessments by the review point (15th February 2019) if contractors are planning to claim for two of the quality criteria of the Quality Payments Scheme.

It is important to note, that it is common to require more than one attempt at CPPE e-assessments before passing and also that if a pharmacy professional, who is required to complete the CPPE risk management training, fails the e-assessment, they will not be able to re-take the assessment for 20 hours. Contractors are therefore advised to consider these points to ensure staff are given enough time to complete their training and pass the e-assessment before the review point.

The first training package is the CPPE Risk management guide and e-assessment, which relates to the first element of the following quality criteria:

  • On the day of the review, 80% of all registered pharmacy professionals* working at the pharmacy have satisfactorily completed the CPPE Risk Management training; and the pharmacy has available for inspection at the review point, at premises level, an example of a risk review that the pharmacy team at the premises have drawn up for a risk in that pharmacy that has been identified and prioritised with identified risk minimisation actions that the pharmacy team is taking.

PSNC has produced a CPPE Risk management record sheet  which contractors can choose to use to record details of the pharmacy professionals who have successfully completed the guide and e-assessment.

The second training package is the CPPE Children’s oral health e-learning (in the form of a video) and e-assessment, which relates to the second element of the following quality criteria:

  • On the day of the review the pharmacy is a Healthy Living Pharmacy level 1 (self-assessment) and; 80% of staff working at the pharmacy (including pharmacy professionals*) that provide healthcare advice to the public have successfully completed the CPPE children’s oral health training assessment.

PSNC has produced a CPPE Children’s oral health record sheet which contractors can choose to use to record details of the members of staff who have watched the e-learning video and successfully completed the e-assessment.

Contractors are advised to retain copies of the CPPE certificates of completion for all staff members after they have passed the relevant e-assessments as evidence of meeting the two quality criteria.

*Pharmacy professionals are pharmacists and pharmacy technicians.

FAQs

Q. Are locum staff included in the requirements to complete the CPPE learning packages and e-assessments?
Yes. This includes locum staff working in the pharmacy on the day of the review so contractors should encourage temporary staff, such as locum pharmacists, to undertake the training and e-assessments.

Q. Are part-time staff included in the requirements to complete the CPPE learning packages and e-assessments?
Yes. This quality criterion applies to all relevant  staff members working at the pharmacy. The number of hours a member of staff is employed for is not relevant for the two quality criteria.

Q. Are non-GPhC registered staff able to register with CPPE to complete the children’s oral health training?
Yes. CPPE has enabled staff who are not registered with the General Pharmaceutical Council (GPhC) to register on the CPPE website as ‘non-registrants’ to complete this training material.

If contractors have members of staff who are unable to register with CPPE, e.g. those not having a work or personal email address to access registration, then they can complete the children’s oral health e-assessment without registration.

While this will enable the staff member to undertake the e-assessment and, when successful, print off or save the PDF certificate as evidence of meeting this criterion, this will, however, need to be done immediately after the e-assessment as it cannot be saved on the CPPE website. It will also not be possible for CPPE to provide any personalised support, feedback or a CPPE record for that member of staff. Contractors are therefore recommended to encourage members of staff to register with CPPE to complete the e-assessment if at all possible.

Categories: National News

FMD compliance – guidance from the UK FMD Working Group

PSNC News - 29 January 2019 - 4:44pm

Community pharmacies must work towards compliance with the Falsified Medicines Directive (FMD) in time for February 9th deadline irrespective of any Brexit scenario, pharmacy bodies have said today (29th January 2019).

The guidance, from the UK FMD Working Group for Community Pharmacy, follows recent meetings between the regulators, the government and the Working Group itself.

Chair of the Working Group, Raj Patel, said:

“All parties recognise the challenges around FMD and we are confident that the regulators will take a pragmatic and even-handed approach to enforcement.

“Nevertheless, pharmacies must make efforts to be compliant with the new FMD safety features, by the deadline.

“Pharmacies must act promptly, but they must also act properly to ensure they are prepared for the new FMD safety features.

“They must carefully consider the terms of any contract for FMD solutions and make sure they are future-proof in any post-Brexit scenario.

“Other practical adjustments might be required, such as modifying dispensing workflows and all pharmacies will need to update their standard operating procedures.

“However, there will be very few packs of medicines in pharmacies with the FMD safety features, on February 9th, as they will take time to come through the medicines supply system, so inevitably the sector is on a journey towards full implementation.”

From February 9th, pharmacies must check the integrity of the anti-tampering device and scan the 2D barcode to mark each pack as decommissioned (or dispensed) in the FMD database. It is understood there will be significant quantities of medicines in the supply chain that do not carry the new safety features, after February 9th, but they can still be wholesaled and dispensed.

Pharmacies are expected to have clear standard operating procedures in place to empower individuals to make judgement calls they could later justify, rather than disrupt supply to patients.

General Pharmaceutical Council inspectors will not focus unduly on any single issue and will assess the pharmacy in the round considering the health, safety and wellbeing of patients and the public.

Visit the Working Group’s website – FMD Source for more information on FMD.

 

Categories: National News

MHRA medical device alert – FreeStyle Libre flash glucose sensor (Abbott) – Use of barrier methods to reduce skin reactions to the sensor adhesive

PSNC News - 29 January 2019 - 2:06pm

MDA number: MDA/2019/003
Date issued 29th January 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert:

Problem

MHRA is aware that some users of the FreeStyle Libre flash glucose monitoring system are applying barrier creams, patches and sprays before attaching the sensor to reduce skin reactions. These barrier methods have not been tested by the manufacturer and may therefore affect the performance of the device.

The severity of the skin reaction can vary from person to person and for certain users this is a skin hypersensitivity reaction rather than an irritation reaction. For this type of reaction, once the person has become sensitised to the adhesive, every time the sensor is reapplied a skin reaction will occur. With each reapplication, the symptoms might appear more quickly and may worsen.

The manufacturer has confirmed that they have revised the formulation of the adhesive, which will be available to UK customers from April 2019.

Please note this problem may not be unique to the Abbott FreeStyle Libre sensor adhesive. The same actions should be taken if patients experience similar symptoms with a different brand of continuous glucose monitoring system.

Action

  • Identify patients who have reported or may be experiencing skin reactions, which may include erythema, itching and blistering.
  • Consider if continued use of this device for patients with skin reactions is suitable.
  • Consider use of alternative glucose monitoring systems for these patients.

This is consistent with the guidance already provided in the manufacturer’s instructions for use, which state:

Some individuals may be sensitive to the adhesive that keeps the Sensor attached to the skin. If you notice significant skin irritation around or under your Sensor, remove the Sensor and stop using the FreeStyle Libre system. Contact your health care professional before continuing to use the FreeStyle Libre system.

Report adverse events involving these devices through your local incident reporting system and/or your national incident reporting authority as appropriate: England, Scotland, Northern Ireland, Wales. You should also report directly to manufacturers if your local or national systems do not.

Deadlines for actions

Actions underway: 12 February 2019

Actions complete: 26 February 2019

Manufacturer contacts

Abbott Diabetes Care UK 
Customer Services Complaints (82) 
Freepost RRBS-BLAA-SEHT 
Maidenhead, 
SL6 4UD, 
United Kingdom 

Tel: 0800 170 1177

Opening Times: 08:00 – 22:00, Monday to Friday (excluding bank holidays)

ADChelpuk@abbott.com

Categories: National News

Are you checking your flu vaccination payments?

PSNC News - 29 January 2019 - 11:58am

Community pharmacy contractors who are providing the Flu Vaccination Advanced Service are reminded of the importance of checking payments for vaccinations they claimed for.

To mitigate any flu payment issues during the 2018/19 season, PSNC recommends that contractors take the following actions:

  1. If you are claiming using the paper form, ensure you are using the correct claim form, which can be downloaded from the NHS Business Services Authority (NHSBSA) website – failure to use the correct form will result in non-payment.
  2. If you are submitting claims using the digital webform, ensure you select the correct month to claim for. The URL sent to your shared NHSmail account can only be used once each month and any subsequent submissions for that claim month using the same URL will not be possible.
  3. If submitting by paper, make sure you are sending your flu claim form by the 5th of the following month in which the vaccinations were administered, along with your end of month prescription bundle.
  4. Although claims will be accepted within six months of the month they were administered in, it is good practice to submit claims as soon as possible to reduce the chances of error.
  5. Keep a copy of your flu claim form (if claiming via the paper claim form) or confirmation email (if claiming digitally) so that you can reconcile the claims against what the NHSBSA pays you.
  6. If you believe that the NHSBSA has made an error with your flu vaccination payments, contact them immediately to resolve any payment issues swiftly. They will endeavour to resolve your query as soon as they can; however, depending upon the nature of the query it may require referral to NHS England for a decision.

Don’t forget: IT platforms such as PharmOutcomes or Sonar may allow you to print out the flu claim form; however, you cannot submit electronic claims for payment using these platforms. You must submit your claim separately to the NHS BSA via the printed form or using the digital webform.

For more information visit psnc.org.uk/flu

Categories: National News

Quality Payments: Have you had an email about the WES gateway criterion?

PSNC News - 28 January 2019 - 3:10pm

Community pharmacy contractors who did not receive confirmation that their pharmacy had met the Warranted Environment Specification (WES) gateway criterion in an email from the NHS Business Services Authority (NHSBSA) on 16th January 2019, should today receive another email from the NHSBSA to their premises-shared NHSmail account*. This email will state whether their pharmacy has now been assessed, in the second assessment period, as having met the WES gateway criterion of the Quality Payments Scheme  (please note, contractors have until 15th February 2019 to meet the WES gateway criterion; this email will just inform contractors as to whether they currently meet the WES gateway criterion so they can be confident of this before they make their declaration).

For a pharmacy to be assessed to see if it meets the WES gateway criterion in the second assessment period, contractors will need to have accessed the Summary Care Record (SCR) portal from their pharmacy between 11th January 2019 – 24th January 2019. If the SCR portal has not been accessed from the pharmacy, NHS Digital will not have been able to capture the pharmacy’s operating system and browser details. Therefore, NHSBSA will not have been able to assess if the pharmacy has met the WES gateway criterion.

The email will detail one of three possible scenarios:

  1. The SCR portal has been accessed and the pharmacy has been validated as having met the WES gateway criterion;
  2. The SCR portal has been accessed and the pharmacy cannot be validated as the pharmacy does not currently meet the WES gateway criterion (due to the operating system and/or the browser used to access the SCR portal not conforming to the WES requirements); or
  3. The SCR portal has not been accessed so compliance has not been able to be assessed.
If the pharmacy has been validated as having met the gateway criterion

Provided that access to the SCR portal from the pharmacy continues with WES compliant operating systems and browsers, contractors will continue to be assessed as having met this gateway criterion. However, any access of the SCR portal with a non-compliant operating system or browser will then lead to the pharmacy being considered non-compliant and therefore not meeting the gateway criterion.

Contractors are advised to retain the email confirming that they have been validated, as evidence of compliance with the WES gateway criterion.

If the pharmacy cannot be validated as the pharmacy does not meet the gateway criterion

Contractors who are assessed as non-compliant are expected to work with their system suppliers to update to an operating system and browser that complies with the WES requirements, as outlined on page 21 of the NHS England guidance by the February review point (15th February 2019).

When this has been completed, contractors should access the SCR portal again to allow compliance to be reassessed. Contractors do not need to access an individual patient’s SCR for validation of this criterion; contractors just need to open the ‘Find a patient’ screen for NHS Digital to be able to capture the pharmacy’s operating system and browser details.

Contractors will receive another email (if they have not been assessed as meeting the WES gateway criterion), week commencing 11th February 2019, which will advise if they have been validated and have therefore met this gateway criterion in the next assessment period (25th January 2019 – 7th February 2019).

If the pharmacy’s compliance cannot be assessed as the SCR portal has not been accessed

Contractors should access the SCR portal as soon as possible so that the pharmacy’s compliance with the gateway criterion can be assessed and either validated as having met the gateway criterion or contractors can be advised that the pharmacy does not meet the WES requirements, allowing corrective action to be taken by the February review point. Contractors do not need to access an individual patient’s SCR for validation of this criterion; contractors just need to open the ‘Find a patient’ screen for NHS Digital to be able to capture the pharmacy’s operating system and browser details.

Contractors will receive another email, week commencing 11th February 2019, which will advise if they have been validated and have therefore met this gateway criterion in the next assessment period (25th January 2019 – 7th February 2019).

Further information on the WES gateway criterion can be found at psnc.org.uk/qpwes

*The following companies have requested that the WES gateway criterion email is sent to a representative at their head office rather than to individual pharmacy premises-shared NHSmail accounts:

ASDA; Boots; Britannia Pharmacy; WM Brown (kinghurst) Ltd; Daleacre Healthcare Ltd; Day Lewis plc; Dean & Smedley Ltd; Gorgemead t/a Cohens Chemists; Hollowood Chemists Ltd; The Hub Pharmacy Ltd; Jardines (UK) Ltd; Knights Chemists Ltd; Lincolnshire Cooperative Ltd; LloydsPharmacy; HA McParland Limited; JN McGill Ltd; Manichem Ltd; Medicine Clinic Ltd; Medipharmacy Limited; Midcounties Co-operative Pharmacy Group; Morrisons; MW Phillips Chemists; Paydens Ltd; PCT Healthcare; Pharmacy Care Plus Ltd; Raylane Ltd; Rowlands Pharmacy; Safedale Ltd; Shaunaks Ltd; Steven Lo / Lo’s Pharmacy; Superdrug; Tesco; Waremoss Ltd / Kamsons; Warwick Healthcare Ltd; H I Weldrick Ltd; Well; and X-Pharm Ltd. WES emails schedule

The NHSBSA Provider Assurance Team will continue to send out emails to contractors who do not meet the WES gateway criterion and to those who have not accessed the SCR portal for their WES compliance to be assessed on a fortnightly basis. The email schedule is detailed in the table below.

Assessment period Contractors will need to access the SCR portal between these dates to be assessed as to whether they meet the WES gateway criterion Dates when the NHSBSA Provider Assurance Team will email contractors to advise if they have been assessed and whether they meet the WES gateway criterion 1 Between 14th November 2018 – 10th January 2019 16th January 2019 2 Between 11th January 2019 – 24th January 2019 28th January 2019 3 Between 25th January 2019 – 7th February 2019 Week commencing 11th February 2019 4 Between 8th February 2019 – 21st February 2019 Week commencing 25th February 2019

 

Categories: National News

Ask PSNC: Quality Payments FAQs

PSNC News - 28 January 2019 - 11:42am

The team at PSNC has received a number of queries on the Quality Payments Scheme. Below are some of the questions asked in recent weeks.

Q. If I launch the Summary Care Record (SCR) portal, will that be sufficient to meet the WES criterion?
No. In order to assess whether or not the contractor meets the WES criterion, contractors need to access the SCR portal. Contractors do not need to access an individual patient’s SCR for their pharmacy to be assessed; contractors just need to open the ‘Find a patient’ screen.

This will allow NHS Digital to capture the pharmacy’s operating and browser details; NHSBSA can then use this data to assess whether the pharmacy has met the WES gateway criterion and inform contractors of their compliance status.  NHSBSA will send an email to each contractor’s shared premises NHSmail account, which will detail whether NHS Digital has been able to validate the pharmacy as meeting the WES gateway criterion.

Q. I have viewed my NHS website profile and my opening times (including Bank Holidays), the facilities the pharmacy provides and the services the pharmacy provides are all correct. Do I therefore meet the gateway criterion?
No. To meet the gateway criterion, contractors need to have logged in to their NHS website profile and either have edited or validated the opening times (including Bank Holiday opening times), the facilities the pharmacy provides and the services the pharmacy provides during the required time period.

Contractors must validate their profile even if their NHS website profile is correct otherwise they will not meet the gateway criterion and will therefore not be entitled to claim for a Quality Payment.

Q. I am having problems accessing my NHS website profile and can therefore not update my profile. What should I do?
Contractors that do not have editing rights to their profile, should email the NHS website service desk (nhswebsite.servicedesk@nhs.net). It is preferable for this email request to come from the pharmacy’s premises shared NHSmail account, as use of other email accounts may lead to a delay in editing rights being granted, while the validity of the request for editing rights is confirmed. To apply for editing rights, contractors should supply the below information, ideally by copying and pasting the table below into an email and completing the required information.

‘QPSAPPLICATION’ should be added to the subject line of the email; failure to add the code to the subject line may result in a processing delay and increase the risk of a failure to achieve this gateway criterion.

Name: Email address (preferably the pharmacy premises shared NHSmail account): (This will be used as your username on the website). Telephone number: Job title: Organisation: ODS code:


Q. What is meant by two live linked NHSmail accounts?
A live linked NHSmail account is one that has been accessed within the last three months and is enabled to allow the user access to the premises-shared NHSmail account.

Categories: National News
Syndicate content